Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial

Daily co-trimoxazole is recommended for African adults living with human immunodeficiency virus (HIV) irrespective of antiretroviral treatment, immune status, or disease stage. Benefits of continued prophylaxis and whether co-trimoxazole can be stopped following immune reconstitution are unknown. We...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases 2021-09, Vol.73 (6), p.1058-1065
Hauptverfasser:	Laurens, Matthew B, Mungwira, Randy G, Nampota, Nginache, Nyirenda, Osward M, Divala, Titus H, Kanjala, Maxwell, Mkandawire, Felix A, Galileya, Lufina Tsirizani, Nyangulu, Wongani, Mwinjiwa, Edson, Downs, Matthew, Tillman, Amy, Taylor, Terrie E, Mallewa, Jane, Plowe, Christopher V, van Oosterhout, Joep J, Laufer, Miriam K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Retroviral Agents - therapeutic use CD4 Lymphocyte Count HIV Infections - drug therapy HIV Infections - prevention & control Humans Major and Commentaries Malawi - epidemiology Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!